Replimune

ACTIVE

500 Unicorn Park Dr Ste 300, Woburn, Massachusetts, United Stateswww.replimune.comPublic331 employeesEstablished: 2015-03-01

Also known as:

replimune group inc.

repl-us

REPL

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

50.0%

Phase 1

33.3%

Phase 4

16.7%

Trial Status Distribution

Active, not recruiting

16.7%

Recruiting

83.3%

Clinical Trials

Trials sponsored by this organization (6)

Study of RP2 alone and in combination with PD1 Blockade in patients with solid tumours

Phase 1

Active, not recruiting

interventional

May 202486 participants

Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumors

Phase 1

Recruiting

interventional

Oct 201936 participants

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Phase 2

Recruiting

81 participants

Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer (CERPASS)

Phase 2

Recruiting

143 participants

Study of RP2 alone and in combination with PD1 Blockade in patients with solid tumours

Phase 2

Recruiting

32 participants

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Phase 4

Recruiting

13 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations